Second Genome Garners $5,000,000 Series A Financing Round

  • Feed Type
  • Date
    8/9/2011
  • Company Name
    Second Genome
  • Mailing Address
    1700 Owens Street 5th Floor San Francisco, CA 94158
  • Company Description
    Second Genome, a venture-backed Bay Area based life sciences company, is committed to improving the quality of human health through microbiome-based personalized medicine. Founded in 2009 by leading experts in microbial research, molecular diagnostics, and biotechnology R&D, Second Genome is using its proprietary Microbiome Signature Discovery platform to generate novel insights relating the microbiome with a wide range of human health disorders.
  • Website
    http://www.secondgenome.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Second Genome will use the $5 million investment to further its development of microbiome-based personalized medicine solutions for gastrointestinal diseases and disorders.
  • M&A Terms
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Wavepoint Ventures
  • Venture Investor
    Seraph Group

By posting a comment, you agree to our terms and conditions.